Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mahban Darougostar Pars is a prominent Iranian pharmaceutical company and a core subsidiary of the Mahban Group. The company specializes in the distribution, marketing, and sales of a wide range of pharmaceutical products, including finished dosage forms and active pharmaceutical ingredients (APIs). It serves as a critical link in the Iranian healthcare supply chain, ensuring the availability of essential generic medications across various therapeutic areas such as cardiology, gastroenterology, and infectious diseases. By leveraging the manufacturing capabilities of its sister companies, Mahban Darou and Mahban Chemi, Mahban Darougostar Pars provides high-quality healthcare solutions to the domestic market. The company is headquartered in Tehran and maintains an extensive distribution network to serve pharmacies and hospitals nationwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mahban Darougostar Pars.